William V. Padula, PhD
William Padula, PhD is an Assistant Professor of Health Economics in the Leonard D. Shaeffer Center for Health Policy & Economics at University of Southern California in Los Angeles, CA. His work extensively covers the theoretical foundations of medical cost-effectiveness analysis. He has found innovative ways of combining pharmaceutical and health economics methods with data analytics, health system quality improvement, and drug pricing issues. He has performed innovative comparative effectiveness research in the fields of wound care and hospital-acquired condition prevention, particularly regarding pressure injuries (aka “bedsores”).
He also holds adjunct appointments at Johns Hopkins University in the School of Nursing and the Armstrong Institute for Patient Safety and Quality at Johns Hopkins Medicine. Previously, he completed a postdoctoral fellowship in health economics at The University of Chicago and led an AHRQ-funded investigation to develop predictive algorithms of patient risk for pressure injury prevention in hospitals. In addition to over 65 scientific publications, he has received the AcademyHealth Outstanding Dissertation Award and several other international recognitions. He currently serves on the Board of Directors for the National Pressure Ulcer Advisory Panel (NPUAP) and as a Commissioner for the American Nurses Credentialing Center (ANCC) Magnet® Recognition Program.
E: bill.padula@monumentanalytics.com
Principal
Monument Analytics

Academic Affiliation
Assistant Professor of Health Economics in the Leonard D. Shaeffer Center for Health Policy & Economics at University of Southern California, Los Angeles, CA
Education
University of Colorado
University of Chicago
Dartmouth College
Northwestern University
CONSULTING TEAM

Francine Chingcuanco, MHS
MANAGER
Francine Chingcuanco, MHS

Benjamin Cohen, PhD, MPH
MANAGER
Benjamin Cohen, PhD, MPH

Karen Dietz, MHS
MANAGER
Karen Dietz, MHS

Elena Fernandez, PharmD, PhD
MANAGER
Elena Fernandez, PharmD, PhD

Omar Mansour, MHS
MANAGER
Omar Mansour, MHS

Katharine Ozenberger, MS, PhDc
MANAGER
Katharine Ozenberger, MS, PhDc

Danyang Wang, MHS
SENIOR ANALYST
Danyang Wang, MHS

Ellen Hu, MHS
CONSULTANT
Ellen Hu, MHS

Divya Mohan, MHS
CONSULTANT
Divya Mohan, MHS

Emma Tassie, MS
CONSULTANT
Emma Tassie, MS

Jeromie Ballreich, PhD, MS
CONSULTANT
Jeromie Ballreich

Elisabeth H. Hazard, PhD
CONSULTANT
Elisabeth H. Hazard, PhD

You? Join Us
WORK WITH MA
TOP TALENT?
SENIOR SCIENTIFIC ADVISORS

Kim Heithoff, MPH, SCD
SENIOR SCIENTIFIC ADVISOR
Kim Heithoff, MPH, SCD

Daniel Touchette, PharmD, MA, FCCP
SENIOR SCIENTIFIC ADVISOR
Daniel Touchette, PharmD, MA, FCCP

Brett McQueen, PhD
SENIOR SCIENTIFIC ADVISOR
Brett McQueen, PhD
ADVISORY BOARD MEMBERS

Adrian Levy, PhD
ADVISORY BOARD MEMBER
Adrian Levy, PhD

Mark Sculpher, PhD
ADVISORY BOARD MEMBER
Mark Sculpher, PhD
Mark Sculpher is Professor of Health Economics at the Centre for Health Economics, University of York, UK where he leads the Centre’s Programme on Economic Evaluation and Health Technology Assessment. He is also Co-Director of the Policy Research Unit in Economic Evaluation of Health and Care Interventions, a programme of research for the UK Department of Health and Social Care funded by the National Institute for Health Research (NIHR).
Mark has worked in the field of economic evaluation and health technology assessment for over 30 years. He has researched in a range of clinical areas including heart disease, cancer, diagnostics, and public health. He has also contributed to research methods in the field, in particular relating to decision analytic modelling and techniques to handle uncertainty, heterogeneity and generalisability. He is also experienced in economic analysis in low income settings and is principle investigator of the Thanzi la Onse (Health for All) programme in Malawi funded by UK Research and Innovation. He has over 270 peer-reviewed publications and is a co-author of two major text books in the area: Methods for the Economic Evaluation of Health Care Programmes (OUP, 2015 with Drummond, Claxton, Torrance and Stoddart) and Decision Modelling for Health Economic Evaluation (OUP, 2006 with Briggs and Claxton).
Mark is an emeritus member of the UK NIHR College of Senior Investigators. Hehas also been a member of the National Institute for Health and Clinical Excellence (NICE) Technology Appraisal Committee and the NICE Public Health Interventions Advisory Committee. He currently sits on NICE’s Diagnostics Advisory Committee. He chaired NICE’s 2004 Task Group on methods guidance for economic evaluation and advised the Methods Working Party for the 2008 update of this guidance. Mark has advised the UK House of Commons Health and Social Care Select Committee, as well as health systems internationally on health technology assessment methods including those in France, Ireland, Japan, Singapore, Germany, Portugal, Taiwan and New Zealand. He has been a member of the Commissioning Board for the UK NHS Health Technology Assessment Programme, the UK NIHR /Medical Research Council’s Methodology Research Panel and the UK Department of Health’s Policy Research Programme’s Commissioning Panel. He served as President of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) (2011-12).

Rob Rayl, MBA
ADVISORY BOARD MEMBER
Rob Rayl, MBA
Rob is currently the President of R2 Medical Solutions. Rob advises small- to mid-size domestic and international companies in the biotechnology, pharmaceutical, and medical device sectors on strategy and commercial execution in the US.
With more than two decades of experience, Rob has driven multi-million-dollar revenue growth for market leading companies in Oncology, Wound Care, Pressure Injury Prevention, and Infection Control. As President, US at Molnlycke Health Care, Rob differentiated their product solutions with clinical and health economics outcomes data.
Since 2014, Rob has been on the board of debra of America and currently serves as the Chief Development Officer (CDO) and Chief Operating Officer (COO). Debra of America is dedicated to improving the quality life of all people living with Epidermolysis Bullosa (EB) by providing free programs and services and funding innovative research.
Rob holds an Executive MBA in Leadership from the University of Georgia, Terry College of Business, a BS in Marketing Management from Valparaiso University, and a Certificate in Leadership from the University of Virginia Darden School of Business.